Received: 24 April 2019
Revised: 26 July 2019
Accepted: 29 July 2019
First Online: 9 August 2019
Ethics approval and consent to participate
: All the procedures presented in this work were approved by the Ethics Committee of Universidad de los Andes. AT samples were obtained with the informed consent of donors.
: Not applicable
: GZ and DM receive stipends from Consorcio REGENERO, a Chilean Biotechnology Company, for cell therapy development. MK receives stipends from Cells for Cells, a Chilean Biotechnology Company, for cell therapy development. CS, RC, and WG declare that they have no competing interests.